TITLE

Risk factors for HIV infection in Males who have Sex with Males (MSM) in Bangladesh

AUTHOR(S)
Chan, Philip A.; Khan, Omar A.
PUB. DATE
January 2007
SOURCE
BMC Public Health;2007, Vol. 7 Issue 1, p153
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Recent surveillance data from Bangladesh indicate rising HIV infection among intravenous drug users (IDU) in the country. We suggest a likely association between HIV risk factors in this group and other groups, such as males who have sex with males (MSM). Methods: Data on MSM in Bangladesh was collected and analyzed from numerous primary and secondary sources, including government ministries, non-profit health organizations, and personal communications. Results: The overall prevalence of HIV in Bangladesh is relatively low, but surveillance data indicate that infection has reached significant proportions in certain high-risk groups and may soon spread to other groups, specifically MSM. Conclusion: The epidemiology of HIV infection in other countries suggests that increasing rates of HIV in higher-risk populations can precede an epidemic in the general population. We review the data concerning MSM, IDU and HIV in Bangladesh from a variety of sources and propose ways to prevent HIV transmission.
ACCESSION #
29362032

 

Related Articles

  • High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection. Brenner, Bluma G.; Roger, Michel; Routy, Jean-Pierre; Moisi, Daniela; Ntemgwa, Michel; Matte, Claudine; Baril, Jean-Guy; Thomas, Réjean; Rouleau, Danielle; Bruneau, Julie; Leblanc, Roger; Legault, Mario; Tremblay, Cecile; Charest, Hugues; Wainberg, Mark A. // Journal of Infectious Diseases;4/1/2007, Vol. 195 Issue 7, p951 

    Background. A population-based phylogenetic approach was used to characterize human immunodeficiency virus (HIV)-transmission dynamics in Quebec. Methods. HIV-1 pol sequences included primary HIV infections (PHIs; <6 months after seroconversion) from the Quebec PHI cohort (1998-2005; n = 215)...

  • POST EXPO. Walsh, Noel // Gay Community News;Feb2005, Issue 182, p20 

    This article focuses on Post Exposure Prophylaxis (PEP), a new treatment for people exposed to HIV. PEP is a four-week course of drugs one can take if one has been exposed to HIV. The PEP drugs, which must be prescribed by a doctor, are actually the same drugs that are given to HIV positive...

  • Prevalence of HIV/AIDS and Prediction of Future Trends in North-west Region of India: A Six-year ICTC-based Study. Vyas, Nitya; Hooja, Saroj; Sinha, Parul; Mathur, Anuj; Singhal, Anita; Vyas, Leela // Indian Journal of Community Medicine;Jul2009, Vol. 34 Issue 3, p212 

    Background: The study was conducted to analyze previous six-year prevalence data of HIV infection in the Northwest region of India and predict future trends for a couple of years. Objectives: The study was conducted to aid SACS and NACO to plan and arrange resources for the future scenario....

  • Preventing HIV Among Latino and African American Gay and Bisexual Men in a Context of HIV-Related Stigma, Discrimination, and Homophobia: Perspectives of Providers. Brooks, Ronald A.; Etzel, Mark A.; Hinojos, Ernesto; Henry, Charles L.; Perez, Mario // AIDS Patient Care & STDs;Nov2005, Vol. 19 Issue 11, p737 

    HIV-related stigma, discrimination, and homophobia impede community-based efforts to combat HIV disease among Latino and African American gay and bisexual men. This commentary highlights ways to address these social biases in communities of color in Los Angeles, California, from the perspectives...

  • Promising outcomes of a national programme for the prevention of mother-to-child HIV transmission in Addis Ababa: a retrospective study. Mirkuzie, Alemnesh H.; Hinderaker, Sven Gudmund; Mørkve, Odd // BMC Health Services Research;2010, Vol. 10, p267 

    Background: Prevention of Mother-to-Child HIV Transmission (PMTCT) is still the most effective intervention in combating new HIV infections. In 2008, revised national PMTCT guidelines that incorporated new policies on HIV counselling and testing, antiretroviral prophylaxis regimen and infant HIV...

  • HIV Status Often Unknown for Tuberculosis Patients in the U.S.  // Clinical Infectious Diseases;1/1/2008, Vol. 46 Issue 1, piv 

    The article provides information on the HIV status that are frequently not known for patients with tuberculosis in the United States. According to data in the "Morbidity and Mortality Weekly Report" released in 2005, nine percent of patients with TB are also identified to have HIV infection....

  • Primary HIV Infection, Phylogenetics, and Antiretroviral Prevention. Pillay, Deenan; Fisher, Martin // Journal of Infectious Diseases;4/1/2007, Vol. 195 Issue 7, p924 

    The article discusses the highly active antiretroviral therapy (HAART) for HIV infection. HAART is the therapy, composed of multiple anti-HIV drugs prescribed to many HIV-positive people, even before they develop symptoms of AIDS. The therapy usually includes one nucleoside analog, or DNA chain...

  • CDC Issues Treatment Guidelines for Nonoccupational HIV Exposure.  // Clinical Infectious Diseases;3/15/2005, Vol. 40 Issue 6, preceding p1 

    The article reports that the U.S. Centers for Disease Control and Prevention have issued guidelines for the use of antiretroviral drugs to prevent HIV infection after non-occupational exposure through sexual intercourse, sexual assault, injection drug use, or accidents. The guidelines recommend...

  • AIDS Drug Assistance Programs in the Era of Routine HIV Testing. Bassett, Ingrid V.; Farel, Claire; Szmuilowicz, Emily D.; Walensky, Rochelle P. // Clinical Infectious Diseases;9/1/2008, Vol. 47 Issue 5, p695 

    AIDS [Acquired Immunodeficiency Syndrome] Drug Assistance Programs, operating within the larger Ryan White Program, are state-based, discretionary programs that provide a drug "safety net" for low-income and uninsured individuals infected with human immunodeficiency virus (HIV). Although the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics